{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T07:49:07Z","timestamp":1781596147786,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020228","name":"Hamburg Foundation for Science Development and Culture Helmut and Hannelore Greve","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["290522633"],"award-info":[{"award-number":["290522633"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["426581255"],"award-info":[{"award-number":["426581255"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO306"],"award-info":[{"award-number":["KFO306"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012680","name":"Universit\u00e4tsklinikum Hamburg-Eppendorf","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012680","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jhepr.2023.100898","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T12:49:12Z","timestamp":1693313352000},"page":"100898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9177-1414","authenticated-orcid":false,"given":"Silja","family":"Steinmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-9938","authenticated-orcid":false,"given":"Johannes","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"F\u00fcssel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5163-6979","authenticated-orcid":false,"given":"Marcial","family":"Sebode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar Wilhelm","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4264-1928","authenticated-orcid":false,"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2023.100898_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement","volume":"19","author":"Lazarus","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100898_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022805","article-title":"Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis","volume":"99","author":"Chalasani","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.jhepr.2023.100898_bib3","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1007\/s10620-016-4213-3","article-title":"Natural history of patients presenting with autoimmune hepatitis and coincident nonalcoholic fatty liver disease","volume":"61","author":"de Luca-Johnson","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2023.100898_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2020.02.001","article-title":"NAFLD and autoimmune hepatitis: do not judge a book by its cover","volume":"75","author":"Dalekos","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jhepr.2023.100898_bib5","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1007\/s10620-016-4258-3","article-title":"Nonalcoholic fatty liver disease in patients with autoimmune hepatitis: further reason for teeth GNASHing?","volume":"61","author":"Weiler-Normann","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2023.100898_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jgh3.12046","article-title":"Non-alcoholic fatty liver disease in patients with autoimmune hepatitis","volume":"2","author":"Takahashi","year":"2018","journal-title":"JGH Open"},{"key":"10.1016\/j.jhepr.2023.100898_bib7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/apt.14968","article-title":"Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom","volume":"48","author":"Dyson","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2023.100898_bib8","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00535-016-1267-0","article-title":"Autoimmune hepatitis in Japan: trends in a nationwide survey","volume":"52","author":"Takahashi","year":"2016","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100898_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jsbmb.2015.07.020","article-title":"Glucocorticoids and non-alcoholic fatty liver disease","volume":"154","author":"Woods","year":"2015","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jhepr.2023.100898_bib10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2147\/DMSO.S247379","article-title":"Glucocorticoid-induced fatty liver disease","volume":"13","author":"Rahimi","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jhepr.2023.100898_bib11","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"Marchesini","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100898_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cld.1045","article-title":"Nonalcoholic fatty liver disease and recent guideline updates","volume":"17","author":"Ando","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"10.1016\/j.jhepr.2023.100898_bib13","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100898_bib14","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.jhepr.2023.100898_bib15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/j.1478-3231.2012.02781.x","article-title":"Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography","volume":"32","author":"Myers","year":"2012","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100898_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12876-019-0961-9","article-title":"Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"19","author":"Pu","year":"2019","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100898_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101547","article-title":"Accuracy of controlled\u00a0attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"51","author":"Cao","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jhepr.2023.100898_bib18","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10620-020-06269-4","article-title":"How good are controlled attenuation parameter scores from fibroscan to assess steatosis, NASH, and fibrosis?","volume":"66","author":"Trowell","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2023.100898_bib19","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/jgh.12134","article-title":"Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance?","volume":"28","author":"Kumar","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100898_bib20","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/liv.14325","article-title":"Controlled attenuation parameter reflects steatosis in compensated advanced chronic liver disease","volume":"40","author":"Piccinni","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2023.100898_bib21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2023.100898_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cld.2017.08.003","article-title":"The Natural history of nonalcoholic fatty liver disease-an evolving view","volume":"22","author":"Lindenmeyer","year":"2018","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhepr.2023.100898_bib23","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1053\/j.gastro.2018.08.024","article-title":"Risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease","volume":"155","author":"Kanwal","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2023.100898_bib24","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","author":"Chazouilleres","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100898_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of patients with primary biliary cholangitis","volume":"67","author":"Hirschfield","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100898_bib26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","author":"Lohse","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100898_bib27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group","volume":"76","author":"Pape","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2023.100898_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jhep.2016.05.023","article-title":"Transient elastography in autoimmune hepatitis: timing determines\u00a0the impact of inflammation and fibrosis","volume":"65","author":"Hartl","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100898_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2003-36419","article-title":"Minilaparoscopy in the diagnosis of cirrhosis: superiority in patients with Child-Pugh A and macronodular disease","volume":"35","author":"Helmreich-Becker","year":"2003","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhepr.2023.100898_bib30","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100898_bib31","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100898_bib32","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhepr.2023.100898_bib33","article-title":"Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis","volume":"3","author":"Laschtowitz","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2023.100898_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"10.1016\/j.jhepr.2023.100898_bib35","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF02295996","article-title":"Note on the sampling error of the difference between\u00a0correlated proportions or percentages","volume":"12","author":"McNemar","year":"1947","journal-title":"Psychometrika"},{"key":"10.1016\/j.jhepr.2023.100898_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/2050640619900820","article-title":"Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis","volume":"8","author":"Semmler","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jhepr.2023.100898_bib37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jhep.2017.05.005","article-title":"Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter","volume":"67","author":"Wong","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhepr.2023.100898_bib38","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3748\/wjg.v27.i1.80","article-title":"Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases","volume":"27","author":"Ni","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2023.100898_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2023.100898_bib40","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1007\/s10620-014-3051-4","article-title":"Prevalence and relevance of nonalcoholic fatty liver disease in patients with primary sclerosing cholangitis","volume":"59","author":"Doycheva","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2023.100898_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.humpath.2017.09.008","article-title":"Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease","volume":"69","author":"Bosch","year":"2017","journal-title":"Hum Pathol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592300229X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592300229X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:07:41Z","timestamp":1778904461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258955592300229X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S258955592300229X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100898","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2023.100898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100898"}}